HFA Premium Access

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Congress Presentation

About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
34 presentations
0 follower

11 more presentations in this session

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Speaker: Doctor Y. Khariton (Kansas City, US)

Thumbnail

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Thumbnail

Discussion - ARM-CAD

Thumbnail

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Speaker: Professor K. Branch (Seattle, US)

Thumbnail

Discussion - COMPASS CHF

Thumbnail

Access the full session

Late breaking trial IV - Registries

Speakers: Professor D. Kotecha, Doctor Y. Khariton, Professor K. Branch
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb